Many of us in the PMNNG consider Phil Falkowitz to be a larger-than-life inspiration. Now we can say that that is literally true. 

A mural featuring a likeness of Phil is being featured at ASH 2017 by Celgene. This is a truly fitting honor for Phil because he was one of the first multiple myeloma patients to participate in a Revlimid (lenalidomide) trial. Phil also serves in Celgene's "Ambassadors" program, helping to educate other patients.

Congratulations, Phil, on this tribute. And thanks for all you do as an advocate!